Expand LNAI Menu
LNAI MENU

LNAI Latest Press Releases

-- August 4, 2026 --

Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 PRNewswire 3:30 PM
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit PRNewswire 9:20 AM

-- June 17, 2026 --

LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS PRNewswire 9:16 AM

-- May 28, 2026 --

Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration PRNewswire 9:15 AM

-- May 22, 2026 --

Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock PRNewswire 9:15 AM

-- May 20, 2026 --

LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT PRNewswire 9:15 AM

-- May 13, 2026 --

CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research Globe Newswire 8:30 AM

-- May 12, 2026 --

Dickinson Wright and Fox Rothschild Join Forces to File Lawsuit Against 'John Doe' 'Naked' Short-Sellers of Lunai Common Stock Globe Newswire 12:13 AM

-- May 4, 2026 --

Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP PRNewswire 9:35 AM

-- April 15, 2026 --

Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships PRNewswire 9:10 AM

-- April 7, 2026 --

Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion PRNewswire 9:05 AM

-- March 26, 2026 --

Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications PRNewswire 8:50 AM

-- March 19, 2026 --

Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model PRNewswire 9:58 AM
Market Data Delayed 15 Minutes